1 Apr 2022
Vet Times Extra: management of canine OA
This thought-provoking podcast explores the owner perspective on canine osteoarthritis management, helping vets achieve greater understanding of their dog owning clients and appreciate how this can improve patient care.
Hannah Capon and Gwen Covey-Crump analyse the importance of not only achieving compliance, but also adherence and concordance (plus what those terms actually mean!).
They also discuss new approaches and products that can positively impact the success of a canine OA care plan, including the first and only weekly oral NSAID, Daxocoxยฎ.
Hannah Capon, MA, VetMB, MRCVS
Hannah is the founder/director of Canine Arthritis Management (CAM). A small animal vet who has worked in a wide range of first opinion practices around the UK, she has faced challenges of sole charge, large team practices, hospital, emergency and night work. She is also a registered Galen myotherapist.
Gwen Covey-Crump, BVetMed, CertVA, Dip.ECVAA, MRCVS
Gwen is lead clinical specialist of the Small Animal Rehabilitation and Pain Management Service at Langford Vets.
After graduating in 2001 she spent three years in small animal practice before commencing a residency in Veterinary Anaesthesia at the University of Bristol, after which she spent a year in clinical anaesthesia practice at the Queenโs Veterinary Hospital, University of Cambridge.
Gwen returned to Bristol in 2009 as the team lead Clinical Anaesthetist for Langford Veterinary Services and obtained the European Diploma in Veterinary Anaesthesia and Analgesia in 2012.
SPONSORED
Todayโs podcast is sponsored by Daxocox, the first and only weekly oral NSAID. Daxocox not only achieves significant improvement of clinical signs associated with the pain of osteoarthritis in dogs, but also helps reduce the risk of breakthrough pain.
Did you know? 88% of owners of dogs with osteoarthritis said that weekly NSAID dosing would be:
- Easier to remember, or
- They would be less likely to miss a dose, or
- Would help control their dogโs pain better
For more information, visit www.daxocox.co.uk
๐ฃ๐บ๐๐๐ผ๐๐ยฎ๐ฃ๐ง๐๐, ๐ฅ๐ข๐๐, ๐ฆ๐ง๐๐, ๐ฉ๐ข๐๐ ๐บ๐๐ฝ ๐ฃ๐ข๐ข๐๐ ๐๐พ๐พ๐๐ ๐ ๐๐บ๐ป๐ ๐พ๐๐ ๐ฟ๐๐ ๐ฝ๐๐๐. ๐ ๐ผ๐๐๐๐พ ๐๐๐ป๐๐๐บ๐๐ผ๐พ: ๐ค๐๐ฟ๐ ๐๐ผ๐๐๐๐ป. ๐ด๐ช ๐ฏ๐ฎ๐ฌ-๐ต, ๐ฃ๐ง๐๐ ๐ต๐๐ฅ๐ค๐ฉ๐ฆ๐ค/๐ง๐ข๐ข๐ฃ ๐ค๐ด/๐ค/๐ค๐ฃ/๐ค๐ฉ๐ข/๐ข๐ข๐ฃ-๐ข๐ข๐ฉ, ๐ฅ๐ข๐๐ ๐ต๐ ๐ฅ๐ค๐ฉ๐ฆ๐ค/๐ง๐ข๐ข๐ค ๐ค๐ด/๐ค/๐ค๐ฃ/๐ค๐ฉ๐ข/๐ข๐ข๐ช-๐ข๐ฃ๐ฆ, ๐ฆ๐ง๐๐ ๐ต๐ ๐ฅ๐ค๐ฉ๐ฆ๐ค/๐ง๐ข๐ข๐ฅ ๐ค๐ด/๐ค/๐ค๐ฃ/๐ค๐ฉ๐ข/๐ข๐ฃ๐ง-๐ข๐ค๐ฃ, ๐ฉ๐ข๐๐ ๐ต๐ ๐ฅ๐ค๐ฉ๐ฆ๐ค/๐ง๐ข๐ข๐ฆ ๐ค๐ด/๐ค/๐ค๐ฃ/๐ค๐ฉ๐ข/๐ข๐ค๐ค-๐ข๐ค๐ช, ๐ฃ๐ข๐ข๐๐ ๐ต๐ ๐ฅ๐ค๐ฉ๐ฆ๐ค/๐ง๐ข๐ข๐ง ๐ค๐ด/๐ค/๐ค๐ฃ/๐ค๐ฉ๐ข/๐ข๐ค๐ซ-๐ข๐ฅ๐ง. ๐จ๐๐ฝ๐๐ผ๐บ๐๐๐๐๐ ๐ฟ๐๐ ๐๐๐พ: ๐ฅ๐๐ ๐๐๐พ ๐๐๐พ๐บ๐๐๐พ๐๐ ๐๐ฟ ๐๐บ๐๐ ๐บ๐๐ฝ ๐๐๐ฟ๐ ๐บ๐๐๐บ๐๐๐๐ ๐บ๐๐๐๐ผ๐๐บ๐๐พ๐ฝ ๐๐๐๐ ๐๐๐๐พ๐๐บ๐๐๐๐๐๐๐๐ (๐๐ ๐ฝ๐พ๐๐พ๐๐พ๐๐บ๐๐๐๐พ ๐๐๐๐๐ ๐ฝ๐๐๐พ๐บ๐๐พ) ๐๐ ๐ฝ๐๐๐. ๐ฅ๐๐๐๐๐พ๐๐๐๐ฟ๐๐๐๐บ๐๐๐๐ ๐ผ๐บ๐ ๐ป๐พ ๐ฟ๐๐๐๐ฝ ๐๐ ๐๐๐พ ๐ฒ๐ฏ๐ข, ๐๐๐พ ๐ฝ๐บ๐๐บ๐๐๐พ๐พ๐ ๐๐ ๐๐๐พ ๐๐บ๐ผ๐ ๐ ๐พ๐บ๐ฟ๐ ๐พ๐. ๐ด๐ฒ๐ค ๐ฌ๐ค๐ฃ๐จ๐ข๐จ๐ญ๐ค๐ฒ ๐ฑ๐ค๐ฒ๐ฏ๐ฎ๐ญ๐ฒ๐จ๐ก๐ซ๐ธ. ๐ฃ๐บ๐๐๐ผ๐๐ยฎ ๐๐ ๐บ๐๐พ๐๐๐๐๐พ๐๐พ๐ฝ ๐๐๐บ๐ฝ๐พ๐๐บ๐๐ ๐๐ฟ ๐ ๐๐๐๐บ๐ ๐ผ๐บ๐๐พ ๐ฆ๐๐๐๐ ๐ฏ๐ ๐ผ.